Timing factors as prognostic variables in patients with head and neck squamous cell carcinoma treated with adjuvant radiotherapy: a literature review

Imagem de Miniatura
Arquivos
art_FRANCO_Timing_factors_as_prognostic_variables_in_patients_with_2020.PDF (140.23 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2020
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Autores
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.66, n.3, p.380-384, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
INTRODUCTION: Radiotherapy (RT) plays an important role in the treatment of patients with head and neck neoplasia, and is frequently used as postoperative adjuvant therapy. This study aimed to review the literature about timing factors that may influence the clinical outcomes of patients with advanced head and neck neoplasia treated with adjuvant RT. RESULTS: Timing factors such as total treatment time, length of adjuvant RT, and the absence of interruptions during RT may influence the clinical outcome of these patients. CONCLUSIONS: In the same way that certain tumor factors can affect the prognosis of patients with squamous cell carcinoma of the head and neck, some therapeutic timing factors are also prognostic factors and therefore, must be carefully orchestrated in order to avoid loss at therapeutic outcomes for these patients.
Palavras-chave
Head and neck neoplasms, Radiotherapy, Carcinoma, squamous cell, Prognosis, Review literature as topic
URI
https://observatorio.fm.usp.br/handle/OPI/37103
Referências
  1. Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X
  2. Awwad HK, 2002, BRIT J CANCER, V86, P517, DOI 10.1038/sj.bjc.6600119
  3. Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641
  4. Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646
  5. DEVITA VT, 1983, CANCER, V51, P1209, DOI 10.1002/1097-0142(19830401)51:7<1209::AID-CNCR2820510707>3.0.CO;2-J
  6. Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
  7. Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762
  8. Graboyes EM, 2017, CANCER-AM CANCER SOC, V123, P2651, DOI 10.1002/cncr.30651
  9. Hliniak A., 2000, Radiotherapy and Oncology, V56, pS5
  10. Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171
  11. Langendijk JA, 2003, INT J RADIAT ONCOL, V57, P693, DOI 10.1016/S0360-3016(03)00624-2
  12. Lundahl RE, 1998, INT J RADIAT ONCOL, V40, P529, DOI 10.1016/S0360-3016(97)00817-1
  13. MACCOMB WS, 1957, AMER J ROENTGENOL RA, V77, P397
  14. MALAISE E, 1966, CR ACAD SCI D NAT, V263, P292
  15. National Comprehensive Cancer Network I, 2017, NCCN CLIN PRACT GUID
  16. Overgaard J., 2000, Radiotherapy and Oncology, V56, pS4
  17. PARSONS JT, 1988, INT J RADIAT ONCOL, V14, P649, DOI 10.1016/0360-3016(88)90085-5
  18. Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4
  19. Rosenthal DI, 2017, INT J RADIAT ONCOL, V98, P1002, DOI 10.1016/j.ijrobp.2017.02.218
  20. Rosenthal DI, 2002, HEAD NECK-J SCI SPEC, V24, P115, DOI 10.1002/hed.10038
  21. SCHIFF PB, 1990, J SURG ONCOL, V43, P203, DOI 10.1002/jso.2930430403
  22. Stephens TC, 1980, RAD BIOL CANCER RES, P385
  23. Suwinski R, 2003, INT J RADIAT ONCOL, V56, P399, DOI 10.1016/S0360-3016(02)04469-3
  24. VIKRAM B, 1979, INT J RADIAT ONCOL, V5, P1837, DOI 10.1016/0360-3016(79)90568-6
  25. WITHERS HR, 1995, INT J RADIAT ONCOL, V33, P549, DOI 10.1016/0360-3016(95)00228-Q
  26. WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - ODS/03